secwatch.observer — SEC 8-K summary
======================================

Issuer:     VBI Vaccines Inc/BC (—)
CIK:        0000764195
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001493152-24-030073
Event type: other_material
Sentiment:  negative
Materiality: 0.95
Item codes: 1.03, 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VBI Vaccines files for bankruptcy restructuring under CCAA and Chapter 15; Nasdaq delisting effective Aug 8
--------------------------------------------------------------------------------

- Received provisional relief under Chapter 15 on Aug 2, 2024; further hearing scheduled for recognition of CCAA order.
- Nasdaq notified delisting effective Aug 8, 2024; company will not appeal.
- Delisting based on noncompliance with minimum stockholders' equity and bid price rules.
- Expects to cease reporting as a public company; no plans to list elsewhere.
- Ernst & Young appointed as monitor in CCAA proceedings and sale solicitation process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/764195/000149315224030073/0001493152-24-030073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/764195/000149315224030073/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-030073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer